

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.76492336 |
| 2 | alanine transport (GO:0032328) | 6.43687338 |
| 3 | negative regulation of astrocyte differentiation (GO:0048712) | 6.24599693 |
| 4 | L-amino acid import (GO:0043092) | 5.99548681 |
| 5 | C4-dicarboxylate transport (GO:0015740) | 5.94928936 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 5.74435982 |
| 7 | amino acid import (GO:0043090) | 5.72714080 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.60735301 |
| 9 | cellular response to cholesterol (GO:0071397) | 5.52193354 |
| 10 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.50431863 |
| 11 | sodium ion export (GO:0071436) | 5.42232445 |
| 12 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 5.21066899 |
| 13 | L-serine transport (GO:0015825) | 4.99986990 |
| 14 | glial cell proliferation (GO:0014009) | 4.95361099 |
| 15 | low-density lipoprotein particle remodeling (GO:0034374) | 4.87960518 |
| 16 | parturition (GO:0007567) | 4.83549251 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.80806771 |
| 18 | cell communication by electrical coupling (GO:0010644) | 4.71685961 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.71533662 |
| 20 | postsynaptic membrane organization (GO:0001941) | 4.66979100 |
| 21 | regulation of beta-amyloid formation (GO:1902003) | 4.65163545 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.61735280 |
| 23 | cellular response to sterol (GO:0036315) | 4.59002076 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.54907957 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 4.46400092 |
| 26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.40299830 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38818140 |
| 28 | chondroitin sulfate catabolic process (GO:0030207) | 4.36365653 |
| 29 | serine transport (GO:0032329) | 4.34945233 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.31399430 |
| 31 | cellular sodium ion homeostasis (GO:0006883) | 4.22626754 |
| 32 | response to auditory stimulus (GO:0010996) | 4.22206638 |
| 33 | central nervous system myelination (GO:0022010) | 4.16083144 |
| 34 | axon ensheathment in central nervous system (GO:0032291) | 4.16083144 |
| 35 | exploration behavior (GO:0035640) | 4.15443536 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.13985986 |
| 37 | potassium ion import (GO:0010107) | 4.12245272 |
| 38 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.09018248 |
| 39 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.06311414 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.04484364 |
| 41 | regulation of astrocyte differentiation (GO:0048710) | 4.00328335 |
| 42 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.97094495 |
| 43 | neurotransmitter transport (GO:0006836) | 3.96947343 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.96277302 |
| 45 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.96193033 |
| 46 | locomotory exploration behavior (GO:0035641) | 3.95700050 |
| 47 | vocalization behavior (GO:0071625) | 3.95696768 |
| 48 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.94331714 |
| 49 | neurotransmitter uptake (GO:0001504) | 3.93832483 |
| 50 | dermatan sulfate metabolic process (GO:0030205) | 3.87066569 |
| 51 | cerebellar granule cell differentiation (GO:0021707) | 3.85942144 |
| 52 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.80154340 |
| 53 | dermatan sulfate biosynthetic process (GO:0030208) | 3.78896510 |
| 54 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.78087380 |
| 55 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.73707245 |
| 56 | atrial cardiac muscle cell action potential (GO:0086014) | 3.70423496 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.68860183 |
| 58 | regulation of ARF protein signal transduction (GO:0032012) | 3.68067010 |
| 59 | negative regulation of glial cell differentiation (GO:0045686) | 3.65740907 |
| 60 | positive regulation of dendritic spine development (GO:0060999) | 3.65732260 |
| 61 | neuron cell-cell adhesion (GO:0007158) | 3.65568858 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 3.62780554 |
| 63 | potassium ion homeostasis (GO:0055075) | 3.60441241 |
| 64 | blood vessel maturation (GO:0001955) | 3.58282724 |
| 65 | regulation of neurotransmitter secretion (GO:0046928) | 3.57740546 |
| 66 | acidic amino acid transport (GO:0015800) | 3.56504168 |
| 67 | neuronal ion channel clustering (GO:0045161) | 3.56335637 |
| 68 | neuromuscular process controlling balance (GO:0050885) | 3.56305730 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.55691909 |
| 70 | ovulation cycle (GO:0042698) | 3.53731901 |
| 71 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.49956798 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.47923083 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 3.46924800 |
| 74 | neuronal action potential propagation (GO:0019227) | 3.46696644 |
| 75 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.46273939 |
| 76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.44774010 |
| 77 | negative regulation of smoothened signaling pathway (GO:0045879) | 3.42446054 |
| 78 | auditory behavior (GO:0031223) | 3.41786430 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.41739750 |
| 80 | cellular response to reactive nitrogen species (GO:1902170) | 3.39095460 |
| 81 | negative regulation of sodium ion transport (GO:0010766) | 3.37977915 |
| 82 | regulation of synapse structural plasticity (GO:0051823) | 3.33993370 |
| 83 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.32733204 |
| 84 | synaptic vesicle endocytosis (GO:0048488) | 3.32433140 |
| 85 | peripheral nervous system axon ensheathment (GO:0032292) | 3.31808772 |
| 86 | myelination in peripheral nervous system (GO:0022011) | 3.31808772 |
| 87 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.31318838 |
| 88 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.28754208 |
| 89 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.26610348 |
| 90 | response to cholesterol (GO:0070723) | 3.25697518 |
| 91 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.25336264 |
| 92 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25203971 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.22735031 |
| 94 | protein localization to synapse (GO:0035418) | 3.21389024 |
| 95 | regulation of cellular amide metabolic process (GO:0034248) | 3.19625283 |
| 96 | regulation of axon regeneration (GO:0048679) | 3.19316536 |
| 97 | regulation of neuron projection regeneration (GO:0070570) | 3.19316536 |
| 98 | proline transport (GO:0015824) | 3.16398531 |
| 99 | neuron-neuron synaptic transmission (GO:0007270) | 3.15776338 |
| 100 | transmission of nerve impulse (GO:0019226) | 3.15254538 |
| 101 | lens fiber cell development (GO:0070307) | 3.12958079 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.12570016 |
| 103 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.12287265 |
| 104 | long-term synaptic potentiation (GO:0060291) | 3.12088149 |
| 105 | regulation of female receptivity (GO:0045924) | 3.11251291 |
| 106 | presynaptic membrane organization (GO:0097090) | 3.10540325 |
| 107 | positive regulation of membrane potential (GO:0045838) | 3.10131007 |
| 108 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.09198967 |
| 109 | glutamate receptor signaling pathway (GO:0007215) | 3.07626814 |
| 110 | astrocyte development (GO:0014002) | 3.07543605 |
| 111 | regulation of dendritic spine development (GO:0060998) | 3.06954235 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.05921034 |
| 113 | L-glutamate transport (GO:0015813) | 3.05630250 |
| 114 | daunorubicin metabolic process (GO:0044597) | 3.04662122 |
| 115 | polyketide metabolic process (GO:0030638) | 3.04662122 |
| 116 | doxorubicin metabolic process (GO:0044598) | 3.04662122 |
| 117 | regulation of postsynaptic membrane potential (GO:0060078) | 3.04216421 |
| 118 | presynaptic membrane assembly (GO:0097105) | 3.04114049 |
| 119 | reverse cholesterol transport (GO:0043691) | 3.00568541 |
| 120 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.00021203 |
| 121 | adenine nucleotide transport (GO:0051503) | 2.99971357 |
| 122 | regulation of synapse maturation (GO:0090128) | 2.99553415 |
| 123 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.99156132 |
| 124 | response to histamine (GO:0034776) | 2.98450609 |
| 125 | membrane repolarization (GO:0086009) | 2.98225866 |
| 126 | neuroblast proliferation (GO:0007405) | 2.97690549 |
| 127 | layer formation in cerebral cortex (GO:0021819) | 2.97671649 |
| 128 | response to methylmercury (GO:0051597) | 2.96873037 |
| 129 | regulation of membrane repolarization (GO:0060306) | 2.96057438 |
| 130 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.95702472 |
| 131 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91263382 |
| 132 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.90760975 |
| 133 | response to sterol (GO:0036314) | 2.90411739 |
| 134 | dendritic spine morphogenesis (GO:0060997) | 2.90331402 |
| 135 | long-term memory (GO:0007616) | 2.89089908 |
| 136 | activation of protein kinase A activity (GO:0034199) | 2.88713871 |
| 137 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88193479 |
| 138 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.87758992 |
| 139 | linoleic acid metabolic process (GO:0043651) | 2.87512517 |
| 140 | oligodendrocyte differentiation (GO:0048709) | 2.86186198 |
| 141 | response to gravity (GO:0009629) | 2.85836298 |
| 142 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.84152625 |
| 143 | sterol catabolic process (GO:0016127) | 2.83790338 |
| 144 | cholesterol catabolic process (GO:0006707) | 2.83790338 |
| 145 | heart trabecula morphogenesis (GO:0061384) | 2.82365847 |
| 146 | regulation of synaptic transmission (GO:0050804) | 2.81637859 |
| 147 | cerebral cortex neuron differentiation (GO:0021895) | 2.81239108 |
| 148 | synaptic vesicle exocytosis (GO:0016079) | 2.80442450 |
| 149 | cGMP-mediated signaling (GO:0019934) | 2.79204563 |
| 150 | synaptic vesicle maturation (GO:0016188) | 2.76895971 |
| 151 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76245139 |
| 152 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75154401 |
| 153 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.74684495 |
| 154 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.73750740 |
| 155 | glutamate secretion (GO:0014047) | 2.73366433 |
| 156 | response to dietary excess (GO:0002021) | 2.72096690 |
| 157 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71915361 |
| 158 | regulation of cholesterol esterification (GO:0010872) | 2.71386274 |
| 159 | glycogen catabolic process (GO:0005980) | 2.71067445 |
| 160 | regulation of response to osmotic stress (GO:0047484) | 2.70667768 |
| 161 | negative regulation of inclusion body assembly (GO:0090084) | 2.70374779 |
| 162 | L-serine metabolic process (GO:0006563) | 2.69254518 |
| 163 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69101984 |
| 164 | cerebellar Purkinje cell layer development (GO:0021680) | 2.68763401 |
| 165 | negative regulation of stress fiber assembly (GO:0051497) | 2.67407519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.85626807 |
| 2 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10226609 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92875405 |
| 4 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.91665861 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.85919190 |
| 6 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.80557610 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66241107 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58103245 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58103245 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56060630 |
| 11 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54270092 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53702798 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50542284 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44646200 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.38059210 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32536803 |
| 17 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26375086 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.18903785 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.17885829 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.16781812 |
| 21 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11696725 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99467836 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96458551 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89590030 |
| 25 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.80944593 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76271976 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70730029 |
| 28 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.63952694 |
| 29 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60914423 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59284959 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57652900 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53900014 |
| 33 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53647977 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53175391 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52663243 |
| 36 | RXR_22108803_ChIP-Seq_LS180_Human | 1.51490380 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50695916 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.50493436 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44137782 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43830436 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.42894917 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41291131 |
| 43 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.34739439 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34010723 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30135761 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28593887 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27961777 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27664464 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26697214 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25976328 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25589964 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24875997 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24496630 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24176564 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23010360 |
| 56 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19694741 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19687820 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19615171 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19335449 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18522251 |
| 61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18399345 |
| 62 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18111842 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17458702 |
| 64 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16632003 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15671729 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.14133004 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13788999 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11500483 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10776270 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10307542 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09739309 |
| 72 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09352709 |
| 73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09133481 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08956530 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08255835 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07732350 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04874672 |
| 78 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03121341 |
| 79 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03082441 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02355693 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01293574 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00444446 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99981878 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99851479 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99563124 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99518826 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97914344 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96261179 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95748698 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94923284 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94542055 |
| 92 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93871830 |
| 93 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93034556 |
| 94 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92835562 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92645864 |
| 96 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92350259 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92300667 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90243866 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88079840 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88034339 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86743778 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86300598 |
| 103 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.86084204 |
| 104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86019262 |
| 105 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.86012297 |
| 106 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.85931937 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85880987 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85132387 |
| 109 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.85058960 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84788881 |
| 111 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84379338 |
| 112 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83995565 |
| 113 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83269113 |
| 114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83030386 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83008271 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81957200 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81785823 |
| 118 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81463962 |
| 119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81407580 |
| 120 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.81207765 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80989222 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79911114 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.79657319 |
| 124 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.79516445 |
| 125 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78907740 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78366913 |
| 127 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.77987411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003690_abnormal_glial_cell | 3.90829964 |
| 2 | MP0002254_reproductive_system_inflammat | 3.88115689 |
| 3 | MP0003329_amyloid_beta_deposits | 3.64726750 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.41299499 |
| 5 | MP0005646_abnormal_pituitary_gland | 3.23037951 |
| 6 | MP0002822_catalepsy | 3.22559027 |
| 7 | MP0004858_abnormal_nervous_system | 2.99919367 |
| 8 | MP0004885_abnormal_endolymph | 2.86913920 |
| 9 | MP0000566_synostosis | 2.49491134 |
| 10 | * MP0003635_abnormal_synaptic_transmissio | 2.46845220 |
| 11 | MP0001502_abnormal_circadian_rhythm | 2.45786850 |
| 12 | * MP0001486_abnormal_startle_reflex | 2.39532144 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.36417996 |
| 14 | MP0004270_analgesia | 2.35890617 |
| 15 | MP0009840_abnormal_foam_cell | 2.32213199 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.24495495 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.24386035 |
| 18 | MP0009046_muscle_twitch | 2.21725686 |
| 19 | MP0003075_altered_response_to | 2.19029444 |
| 20 | MP0003879_abnormal_hair_cell | 2.12163537 |
| 21 | MP0002064_seizures | 2.11880361 |
| 22 | MP0009745_abnormal_behavioral_response | 2.10660392 |
| 23 | MP0003279_aneurysm | 2.10500869 |
| 24 | MP0000604_amyloidosis | 2.07764034 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.06904432 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.02705982 |
| 27 | MP0008569_lethality_at_weaning | 1.98435383 |
| 28 | MP0002063_abnormal_learning/memory/cond | 1.98370340 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.96751296 |
| 30 | MP0001984_abnormal_olfaction | 1.92200133 |
| 31 | MP0003634_abnormal_glial_cell | 1.91909728 |
| 32 | MP0003878_abnormal_ear_physiology | 1.91167503 |
| 33 | MP0005377_hearing/vestibular/ear_phenot | 1.91167503 |
| 34 | MP0003011_delayed_dark_adaptation | 1.84250434 |
| 35 | MP0003880_abnormal_central_pattern | 1.71643003 |
| 36 | MP0003633_abnormal_nervous_system | 1.70912735 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.64035076 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.62101907 |
| 39 | MP0003136_yellow_coat_color | 1.61434903 |
| 40 | MP0001853_heart_inflammation | 1.58837914 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.55125134 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.51621698 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.50241318 |
| 44 | MP0003631_nervous_system_phenotype | 1.49585664 |
| 45 | MP0001485_abnormal_pinna_reflex | 1.49561470 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.49096370 |
| 47 | MP0002272_abnormal_nervous_system | 1.45886006 |
| 48 | MP0003632_abnormal_nervous_system | 1.44636531 |
| 49 | MP0005187_abnormal_penis_morphology | 1.42131619 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.39489834 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.37959166 |
| 52 | MP0002736_abnormal_nociception_after | 1.37148510 |
| 53 | MP0002090_abnormal_vision | 1.36635136 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.35139401 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.32518791 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.30630291 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.27583138 |
| 58 | MP0002127_abnormal_cardiovascular_syste | 1.25539386 |
| 59 | MP0001727_abnormal_embryo_implantation | 1.24629385 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.24177872 |
| 61 | MP0000778_abnormal_nervous_system | 1.23919353 |
| 62 | MP0005253_abnormal_eye_physiology | 1.20376507 |
| 63 | MP0004215_abnormal_myocardial_fiber | 1.19174858 |
| 64 | MP0005332_abnormal_amino_acid | 1.18523398 |
| 65 | MP0004142_abnormal_muscle_tone | 1.18449975 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.14491969 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.08422403 |
| 68 | * MP0002733_abnormal_thermal_nociception | 1.08239816 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.07464797 |
| 70 | MP0004924_abnormal_behavior | 1.07464797 |
| 71 | MP0010030_abnormal_orbit_morphology | 1.06154962 |
| 72 | MP0000049_abnormal_middle_ear | 1.06123937 |
| 73 | MP0003787_abnormal_imprinting | 1.04248298 |
| 74 | MP0001905_abnormal_dopamine_level | 0.99109314 |
| 75 | MP0005171_absent_coat_pigmentation | 0.98814200 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.98739207 |
| 77 | MP0006276_abnormal_autonomic_nervous | 0.97860852 |
| 78 | MP0000955_abnormal_spinal_cord | 0.95020551 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.94443199 |
| 80 | MP0000920_abnormal_myelination | 0.94349569 |
| 81 | MP0005166_decreased_susceptibility_to | 0.94070402 |
| 82 | MP0002152_abnormal_brain_morphology | 0.93071420 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.92937574 |
| 84 | * MP0001970_abnormal_pain_threshold | 0.90837254 |
| 85 | MP0008874_decreased_physiological_sensi | 0.90778333 |
| 86 | MP0005165_increased_susceptibility_to | 0.90256592 |
| 87 | MP0000751_myopathy | 0.90063209 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.89166786 |
| 89 | * MP0002066_abnormal_motor_capabilities/c | 0.88943926 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.87246165 |
| 91 | MP0004742_abnormal_vestibular_system | 0.86976395 |
| 92 | MP0004043_abnormal_pH_regulation | 0.85130601 |
| 93 | MP0003172_abnormal_lysosome_physiology | 0.84778031 |
| 94 | MP0000647_abnormal_sebaceous_gland | 0.84380086 |
| 95 | MP0000026_abnormal_inner_ear | 0.84365886 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.83756184 |
| 97 | MP0005647_abnormal_sex_gland | 0.83600054 |
| 98 | MP0005535_abnormal_body_temperature | 0.81917413 |
| 99 | MP0002229_neurodegeneration | 0.81631452 |
| 100 | MP0004130_abnormal_muscle_cell | 0.81578127 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.81324879 |
| 102 | MP0002249_abnormal_larynx_morphology | 0.79562093 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 0.76673166 |
| 104 | MP0001529_abnormal_vocalization | 0.75447892 |
| 105 | MP0000639_abnormal_adrenal_gland | 0.74406480 |
| 106 | MP0005670_abnormal_white_adipose | 0.72509524 |
| 107 | MP0003646_muscle_fatigue | 0.72071240 |
| 108 | MP0002184_abnormal_innervation | 0.71930010 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.69618242 |
| 110 | MP0001177_atelectasis | 0.68860805 |
| 111 | MP0002752_abnormal_somatic_nervous | 0.65659728 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.64926450 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.62559710 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.62329645 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.62309548 |
| 116 | MP0003283_abnormal_digestive_organ | 0.62028009 |
| 117 | MP0004233_abnormal_muscle_weight | 0.61278761 |
| 118 | MP0002735_abnormal_chemical_nociception | 0.58101360 |
| 119 | MP0004085_abnormal_heartbeat | 0.52066848 |
| 120 | MP0004484_altered_response_of | 0.48706955 |
| 121 | MP0003956_abnormal_body_size | 0.47059392 |
| 122 | MP0000747_muscle_weakness | 0.44336544 |
| 123 | MP0003123_paternal_imprinting | 0.43994368 |
| 124 | MP0001346_abnormal_lacrimal_gland | 0.42376994 |
| 125 | MP0001943_abnormal_respiration | 0.40065008 |
| 126 | MP0003045_fibrosis | 0.40059311 |
| 127 | MP0002971_abnormal_brown_adipose | 0.40048872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Megalencephaly (HP:0001355) | 7.92879411 |
| 2 | Aplasia involving bones of the upper limbs (HP:0009823) | 7.02126492 |
| 3 | Aplasia of the phalanges of the hand (HP:0009802) | 7.02126492 |
| 4 | Aplasia involving bones of the extremities (HP:0009825) | 7.02126492 |
| 5 | Neurofibrillary tangles (HP:0002185) | 5.55572317 |
| 6 | Ankle clonus (HP:0011448) | 4.61118536 |
| 7 | Abnormality of binocular vision (HP:0011514) | 4.50916265 |
| 8 | Diplopia (HP:0000651) | 4.50916265 |
| 9 | Bundle branch block (HP:0011710) | 4.41560688 |
| 10 | Hemiparesis (HP:0001269) | 4.37021001 |
| 11 | Abnormality of secondary sexual hair (HP:0009888) | 4.26999028 |
| 12 | Abnormality of the axillary hair (HP:0100134) | 4.26999028 |
| 13 | Febrile seizures (HP:0002373) | 4.20963497 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 4.13378200 |
| 15 | Clumsiness (HP:0002312) | 4.04982396 |
| 16 | Enlarged penis (HP:0000040) | 4.03056526 |
| 17 | Atonic seizures (HP:0010819) | 3.91248507 |
| 18 | Hemiplegia (HP:0002301) | 3.90381514 |
| 19 | Back pain (HP:0003418) | 3.87452199 |
| 20 | Hypoplastic left heart (HP:0004383) | 3.82808799 |
| 21 | Visual hallucinations (HP:0002367) | 3.75569666 |
| 22 | Synostosis involving the elbow (HP:0003938) | 3.72247209 |
| 23 | Humeroradial synostosis (HP:0003041) | 3.72247209 |
| 24 | Gonadotropin excess (HP:0000837) | 3.54866752 |
| 25 | Spastic gait (HP:0002064) | 3.49058570 |
| 26 | Atrioventricular block (HP:0001678) | 3.47172469 |
| 27 | Neonatal hypoglycemia (HP:0001998) | 3.46277398 |
| 28 | Split foot (HP:0001839) | 3.43718145 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.41099200 |
| 30 | Peripheral hypomyelination (HP:0007182) | 3.37485115 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.36752974 |
| 32 | Scanning speech (HP:0002168) | 3.35531833 |
| 33 | Intention tremor (HP:0002080) | 3.34821813 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.27765129 |
| 35 | Dysmetria (HP:0001310) | 3.26471581 |
| 36 | Focal motor seizures (HP:0011153) | 3.23741841 |
| 37 | Urinary urgency (HP:0000012) | 3.23535294 |
| 38 | Increased circulating renin level (HP:0000848) | 3.23253469 |
| 39 | Hypokalemic alkalosis (HP:0001949) | 3.22215827 |
| 40 | Macroorchidism (HP:0000053) | 3.20843635 |
| 41 | Papilledema (HP:0001085) | 3.12807001 |
| 42 | Fibular aplasia (HP:0002990) | 3.06875883 |
| 43 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.06407695 |
| 44 | Obstructive sleep apnea (HP:0002870) | 3.05893760 |
| 45 | Absence seizures (HP:0002121) | 2.98430120 |
| 46 | Pseudobulbar signs (HP:0002200) | 2.96559663 |
| 47 | Adactyly (HP:0009776) | 2.95661747 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.94976894 |
| 49 | Dialeptic seizures (HP:0011146) | 2.92415955 |
| 50 | Heart block (HP:0012722) | 2.91172103 |
| 51 | Hypoplastic heart (HP:0001961) | 2.90971145 |
| 52 | Tetraplegia (HP:0002445) | 2.87624895 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.78683475 |
| 54 | Mutism (HP:0002300) | 2.73095189 |
| 55 | Hyperglycinuria (HP:0003108) | 2.72796693 |
| 56 | Status epilepticus (HP:0002133) | 2.71162879 |
| 57 | Myokymia (HP:0002411) | 2.70296828 |
| 58 | Short hallux (HP:0010109) | 2.70222133 |
| 59 | Absent hair (HP:0002298) | 2.68928187 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.65323303 |
| 61 | Neuronal loss in central nervous system (HP:0002529) | 2.63664287 |
| 62 | Lower limb muscle weakness (HP:0007340) | 2.62450659 |
| 63 | Clonus (HP:0002169) | 2.60685616 |
| 64 | Long nose (HP:0003189) | 2.60244268 |
| 65 | Mixed hearing impairment (HP:0000410) | 2.59571807 |
| 66 | Abnormality of the dental pulp (HP:0006479) | 2.59271909 |
| 67 | Annular pancreas (HP:0001734) | 2.57663680 |
| 68 | Torticollis (HP:0000473) | 2.53699325 |
| 69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.50339196 |
| 70 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.50339196 |
| 71 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.49250977 |
| 72 | Anxiety (HP:0000739) | 2.45886484 |
| 73 | Delusions (HP:0000746) | 2.44547438 |
| 74 | Abnormality of the corticospinal tract (HP:0002492) | 2.43791313 |
| 75 | Confusion (HP:0001289) | 2.43322504 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42718679 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.42718679 |
| 78 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.37393279 |
| 79 | Cerebral hypomyelination (HP:0006808) | 2.36168598 |
| 80 | Onycholysis (HP:0001806) | 2.34744713 |
| 81 | Impaired vibratory sensation (HP:0002495) | 2.34098617 |
| 82 | Akinesia (HP:0002304) | 2.34034442 |
| 83 | Limb dystonia (HP:0002451) | 2.32386296 |
| 84 | Broad alveolar ridges (HP:0000187) | 2.31611965 |
| 85 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.30153404 |
| 86 | Mesangial abnormality (HP:0001966) | 2.28141173 |
| 87 | Potter facies (HP:0002009) | 2.28074091 |
| 88 | Facial shape deformation (HP:0011334) | 2.28074091 |
| 89 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.27965347 |
| 90 | Apathy (HP:0000741) | 2.27334460 |
| 91 | Hammertoe (HP:0001765) | 2.24225600 |
| 92 | Poor eye contact (HP:0000817) | 2.22788160 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 2.22449719 |
| 94 | Hypoalphalipoproteinemia (HP:0003233) | 2.22022137 |
| 95 | Hyperlipoproteinemia (HP:0010980) | 2.21710169 |
| 96 | Bradykinesia (HP:0002067) | 2.21678276 |
| 97 | Focal dystonia (HP:0004373) | 2.20933375 |
| 98 | Dysdiadochokinesis (HP:0002075) | 2.20534671 |
| 99 | Amyloidosis (HP:0011034) | 2.19938992 |
| 100 | Epileptiform EEG discharges (HP:0011182) | 2.17810724 |
| 101 | Tetraparesis (HP:0002273) | 2.15019751 |
| 102 | Impaired smooth pursuit (HP:0007772) | 2.12544056 |
| 103 | Spastic tetraparesis (HP:0001285) | 2.11763287 |
| 104 | Abnormal eating behavior (HP:0100738) | 2.11420935 |
| 105 | Narrow nasal bridge (HP:0000446) | 2.11192497 |
| 106 | Action tremor (HP:0002345) | 2.10237341 |
| 107 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.10163128 |
| 108 | Short middle phalanx of the 5th finger (HP:0004220) | 2.06384184 |
| 109 | Diminished motivation (HP:0000745) | 2.06193420 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 2.05024492 |
| 111 | Neonatal short-limb short stature (HP:0008921) | 2.04956870 |
| 112 | Abnormal EKG (HP:0003115) | 2.04212855 |
| 113 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.03598887 |
| 114 | Dementia (HP:0000726) | 2.03062481 |
| 115 | Bronchomalacia (HP:0002780) | 2.02833822 |
| 116 | Truncal ataxia (HP:0002078) | 2.02506685 |
| 117 | Abnormality of permanent molar morphology (HP:0011071) | 2.01922629 |
| 118 | Abnormality of the dental root (HP:0006486) | 2.01922629 |
| 119 | Taurodontia (HP:0000679) | 2.01922629 |
| 120 | Abnormality of the foot musculature (HP:0001436) | 2.01123601 |
| 121 | Sleep apnea (HP:0010535) | 2.01058912 |
| 122 | Focal seizures (HP:0007359) | 2.00125893 |
| 123 | Abnormality of the periventricular white matter (HP:0002518) | 1.99725050 |
| 124 | Craniofacial dystonia (HP:0012179) | 1.98934066 |
| 125 | Hypoplastic pelvis (HP:0008839) | 1.98802139 |
| 126 | Stereotypic behavior (HP:0000733) | 1.98074714 |
| 127 | Metabolic alkalosis (HP:0200114) | 1.97321698 |
| 128 | Exercise-induced myalgia (HP:0003738) | 1.96337989 |
| 129 | Insomnia (HP:0100785) | 1.95162352 |
| 130 | Coronal craniosynostosis (HP:0004440) | 1.95028962 |
| 131 | Generalized tonic-clonic seizures (HP:0002069) | 1.94810012 |
| 132 | Polygenic inheritance (HP:0010982) | 1.94374603 |
| 133 | Abnormality of nail color (HP:0100643) | 1.93738117 |
| 134 | Progressive cerebellar ataxia (HP:0002073) | 1.93545717 |
| 135 | Choreoathetosis (HP:0001266) | 1.92077064 |
| 136 | Abnormality of molar (HP:0011077) | 1.91737033 |
| 137 | Abnormality of molar morphology (HP:0011070) | 1.91737033 |
| 138 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.91707481 |
| 139 | Postural instability (HP:0002172) | 1.91658814 |
| 140 | Hyporeflexia of lower limbs (HP:0002600) | 1.90577118 |
| 141 | Maternal diabetes (HP:0009800) | 1.90080071 |
| 142 | Testicular neoplasm (HP:0010788) | 1.90079960 |
| 143 | Polyphagia (HP:0002591) | 1.89746307 |
| 144 | Autoamputation (HP:0001218) | 1.89171914 |
| 145 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.88829991 |
| 146 | Rigidity (HP:0002063) | 1.88174605 |
| 147 | Ketoacidosis (HP:0001993) | 1.87118764 |
| 148 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86404128 |
| 149 | Bradycardia (HP:0001662) | 1.86403558 |
| 150 | Abnormal social behavior (HP:0012433) | 1.85007848 |
| 151 | Impaired social interactions (HP:0000735) | 1.85007848 |
| 152 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84228874 |
| 153 | Multifactorial inheritance (HP:0001426) | 1.83915863 |
| 154 | Decreased motor nerve conduction velocity (HP:0003431) | 1.83322653 |
| 155 | Alacrima (HP:0000522) | 1.82781558 |
| 156 | Sensorimotor neuropathy (HP:0007141) | 1.81541981 |
| 157 | Absent toe (HP:0010760) | 1.80527268 |
| 158 | Athetosis (HP:0002305) | 1.79043283 |
| 159 | Abnormal urine output (HP:0012590) | 1.73684700 |
| 160 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.73457412 |
| 161 | Paraparesis (HP:0002385) | 1.71578913 |
| 162 | Turricephaly (HP:0000262) | 1.71359062 |
| 163 | Median cleft lip (HP:0000161) | 1.70008400 |
| 164 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.69633550 |
| 165 | Cutaneous syndactyly (HP:0012725) | 1.68869009 |
| 166 | Depression (HP:0000716) | 1.67863279 |
| 167 | Abnormality of homocysteine metabolism (HP:0010919) | 1.64793338 |
| 168 | Homocystinuria (HP:0002156) | 1.64793338 |
| 169 | Oligodactyly (hands) (HP:0001180) | 1.62340826 |
| 170 | Limb ataxia (HP:0002070) | 1.61710206 |
| 171 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.60543328 |
| 172 | Abnormality of proline metabolism (HP:0010907) | 1.59720848 |
| 173 | Hydroxyprolinuria (HP:0003080) | 1.59720848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.86696094 |
| 2 | LMTK2 | 5.59909090 |
| 3 | PHKG2 | 4.49895129 |
| 4 | PHKG1 | 4.49895129 |
| 5 | TNIK | 4.35504079 |
| 6 | NTRK2 | 3.37345628 |
| 7 | MUSK | 3.09507576 |
| 8 | UHMK1 | 2.90715923 |
| 9 | PRKD3 | 2.65966067 |
| 10 | PAK2 | 2.51005639 |
| 11 | SIK1 | 2.35992839 |
| 12 | NTRK3 | 2.20621728 |
| 13 | TRIB3 | 2.03164248 |
| 14 | CASK | 1.58728279 |
| 15 | MAPK12 | 1.52195374 |
| 16 | SGK2 | 1.49646025 |
| 17 | MAPK13 | 1.49215200 |
| 18 | MINK1 | 1.41559557 |
| 19 | SGK494 | 1.36585484 |
| 20 | SGK223 | 1.36585484 |
| 21 | PRPF4B | 1.30868616 |
| 22 | ARAF | 1.25497260 |
| 23 | PKN1 | 1.23172394 |
| 24 | SGK3 | 1.20181715 |
| 25 | FGR | 1.16886110 |
| 26 | EEF2K | 1.09893413 |
| 27 | PRKCG | 1.06984691 |
| 28 | MAP2K7 | 1.06265498 |
| 29 | PINK1 | 1.03092189 |
| 30 | MAP3K4 | 1.02240822 |
| 31 | LATS2 | 0.99044760 |
| 32 | MARK1 | 0.98737946 |
| 33 | FGFR2 | 0.97058205 |
| 34 | CDK5 | 0.96764536 |
| 35 | BMPR2 | 0.95121635 |
| 36 | MAP3K2 | 0.88671352 |
| 37 | IRAK3 | 0.88415041 |
| 38 | GRK6 | 0.86546220 |
| 39 | CAMK2D | 0.83716080 |
| 40 | ADRBK1 | 0.83157846 |
| 41 | PAK6 | 0.82929864 |
| 42 | NTRK1 | 0.82495822 |
| 43 | TYRO3 | 0.82248978 |
| 44 | TNK2 | 0.81811371 |
| 45 | DAPK1 | 0.81207705 |
| 46 | MAP3K9 | 0.79859593 |
| 47 | MAP3K13 | 0.79373320 |
| 48 | MAPKAPK5 | 0.77936025 |
| 49 | DYRK1A | 0.76442797 |
| 50 | ALK | 0.75851086 |
| 51 | DDR2 | 0.74179694 |
| 52 | STK38 | 0.73268016 |
| 53 | MAPK7 | 0.70550387 |
| 54 | INSRR | 0.70164638 |
| 55 | STK11 | 0.70101729 |
| 56 | CAMK2A | 0.69476328 |
| 57 | CAMKK1 | 0.66054499 |
| 58 | PRKCH | 0.65899956 |
| 59 | BMX | 0.65651896 |
| 60 | MAPKAPK3 | 0.65455293 |
| 61 | PRKCE | 0.64774350 |
| 62 | TAOK2 | 0.64523854 |
| 63 | CAMK4 | 0.62777012 |
| 64 | ROCK1 | 0.60850695 |
| 65 | TRPM7 | 0.59435337 |
| 66 | SGK1 | 0.57541339 |
| 67 | CDC42BPA | 0.57172529 |
| 68 | PAK3 | 0.56131437 |
| 69 | CDK3 | 0.56032753 |
| 70 | KSR2 | 0.54959483 |
| 71 | PDK1 | 0.53534558 |
| 72 | SIK2 | 0.53438107 |
| 73 | RIPK4 | 0.53003878 |
| 74 | CDK19 | 0.51421358 |
| 75 | PRKD2 | 0.50630997 |
| 76 | RIPK1 | 0.50387289 |
| 77 | FGFR1 | 0.48898885 |
| 78 | BRSK1 | 0.48540984 |
| 79 | MKNK2 | 0.48055578 |
| 80 | CAMK2G | 0.47916934 |
| 81 | DAPK2 | 0.46901437 |
| 82 | PRKCA | 0.46465653 |
| 83 | ROCK2 | 0.46443647 |
| 84 | DMPK | 0.44960903 |
| 85 | JAK1 | 0.44795078 |
| 86 | RPS6KA3 | 0.44396705 |
| 87 | CDK15 | 0.44370254 |
| 88 | RET | 0.43661872 |
| 89 | CAMK1 | 0.43555048 |
| 90 | RPS6KB1 | 0.42796719 |
| 91 | PRKACG | 0.42167037 |
| 92 | PRKD1 | 0.42162607 |
| 93 | PRKACA | 0.41824144 |
| 94 | MAP2K1 | 0.41812990 |
| 95 | FES | 0.41783944 |
| 96 | IGF1R | 0.41554267 |
| 97 | PRKCZ | 0.41380339 |
| 98 | CDK18 | 0.41366390 |
| 99 | SCYL2 | 0.41062903 |
| 100 | PRKCQ | 0.40301235 |
| 101 | CAMK1G | 0.39909469 |
| 102 | PRKAA2 | 0.39803893 |
| 103 | GRK5 | 0.39436472 |
| 104 | MAP3K7 | 0.37593542 |
| 105 | DAPK3 | 0.37293475 |
| 106 | MAPK4 | 0.37068900 |
| 107 | CDK11A | 0.36854962 |
| 108 | PRKG2 | 0.36487245 |
| 109 | MAP2K4 | 0.35349455 |
| 110 | CSNK1G2 | 0.33824912 |
| 111 | SRC | 0.33303881 |
| 112 | RAF1 | 0.33229415 |
| 113 | PRKG1 | 0.32866354 |
| 114 | CAMK1D | 0.32739269 |
| 115 | NEK6 | 0.32488301 |
| 116 | MAP3K11 | 0.32259967 |
| 117 | MARK2 | 0.31251795 |
| 118 | CDK14 | 0.31000998 |
| 119 | BCKDK | 0.30662057 |
| 120 | PDPK1 | 0.29848213 |
| 121 | FYN | 0.29611823 |
| 122 | FGFR3 | 0.28762451 |
| 123 | PRKAA1 | 0.28229254 |
| 124 | PDGFRA | 0.27232556 |
| 125 | MAPK10 | 0.27011143 |
| 126 | CAMK2B | 0.26947069 |
| 127 | AKT2 | 0.26087834 |
| 128 | PRKACB | 0.24879799 |
| 129 | ERBB4 | 0.24811726 |
| 130 | CAMKK2 | 0.24593154 |
| 131 | PLK2 | 0.23848738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 6.62034018 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.25664189 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.62929137 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.73144410 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39160000 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.33277756 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32224324 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94879604 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.89072471 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.85479136 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.76871136 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.58750281 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52034008 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48474178 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.41849324 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38639776 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.35169059 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.35053295 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.27974129 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27208093 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27029294 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25751204 |
| 23 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24682321 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23420815 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14865438 |
| 26 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13088371 |
| 27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12931034 |
| 28 | Glioma_Homo sapiens_hsa05214 | 1.07267819 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02391337 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01978054 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01733989 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00537493 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00531151 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00260073 |
| 35 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.95294045 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 0.93831482 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.93802120 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91978697 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89632178 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89148992 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88437592 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 0.87938792 |
| 43 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86857802 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84530302 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83699809 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 0.83167065 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82898943 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82858872 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82089912 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81836069 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81533383 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81486190 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80960790 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77895389 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.77444006 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77150630 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76739291 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76332813 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.76257010 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75420933 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74646781 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74525565 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74342007 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72709981 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72378518 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72172419 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71662674 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71296774 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.70204325 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70159702 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69858146 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68023070 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67808024 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66574409 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.66198448 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66170933 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66003872 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62059445 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60984726 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60617875 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59410501 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59363470 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58918514 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58664118 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.58238187 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58151151 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.57564429 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57524529 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57374098 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55915083 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55316626 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54553372 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54105609 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53904935 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53341047 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52589669 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52393339 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52065376 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51448987 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51297767 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50838849 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50025232 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.49320870 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48097192 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48021061 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47849126 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47062973 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46274680 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46217854 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45629676 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45222632 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45217942 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45024978 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44710814 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44130040 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41229103 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40764431 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40690779 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39264200 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39222379 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38862622 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38014662 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37800106 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.37373133 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37326662 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37214473 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33290492 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33083158 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30772335 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.30131997 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25454390 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23484380 |
| 133 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23401107 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22554448 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22534520 |

